Astrazeneca Ab Drug Patent Portfolio

Astrazeneca Ab's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Astrazeneca Ab News

JNJ vs. AZN: Which Pharmaceutical Stock is the Better Investment? - TradingView

06 Jan, 2026

ABBV or AZN: Which Pharmaceutical Stock Represents a Superior Investment Opportunity at This Time? - TradingView

23 Dec, 2025

5 Major Pharmaceutical Stocks Likely to Excel in 2026 - TradingView

23 Dec, 2025

AstraZeneca's Stock Falls 0.7% Due to Concerns Over Patent Expiration, Yet Robust Pipeline Supports Long-Term Outlook

04 Dec, 2025

See More